Jane Street’s Iterum Therapeutics ITRM Stock Holding History

Jane Street’s Portfolio ITRM Stock Details ITRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-289,410	Closed	-$97K	–	12262
2025 Q4	$97K	Buy	289,410 +274,892	+1,893%	+$148K	﹤0.01%	10202
2025 Q3	$9.73K	Sell	14,518 -78,425	-84%	-$61.4K	﹤0.01%	10580
2025 Q2	$92.5K	Buy	+92,943	New	+$96.9K	﹤0.01%	8985
2025 Q1	–	Sell	-10,262	Closed	-$18.2K	–	10002
2024 Q4	$18.2K	Buy	+10,262	New	+$16.1K	﹤0.01%	9139
2022 Q4	–	Sell	-30,479	Closed	-$49K	–	9609
2022 Q3	$49K	Buy	30,479 +27,997	+1,128%	+$85K	﹤0.01%	8936
2022 Q2	$7K	Buy	+2,482	New	+$9.29K	﹤0.01%	9366
2022 Q1	–	Sell	-8,837	Closed	-$52K	–	10661
2021 Q4	$52K	Buy	8,837 +7,985	+937%	+$61.7K	﹤0.01%	9519
2021 Q3	$7K	Buy	+852	New	+$10.5K	﹤0.01%	9819
2021 Q2	–	Sell	-1,203	Closed	-$25K	–	10086
2021 Q1	$25K	Buy	+1,203	New	+$28.6K	﹤0.01%	8950

Other funds holding ITRM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

GWP

Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's ITRM Position: Q1 2026 in Review

Jane Street sold out of Iterum Therapeutics (ITRM) in Q1 2026, closing a stake of 289,410 shares — an estimated $97K sold.

Jane Street first reported a position in ITRM in Q1 2021 and held it in 9 quarters. The position peaked at $97K in Q4 2025. 18 funds tracked by Wall St. Rank hold ITRM as of Q1 2026.

Jane Street reported no remaining Iterum Therapeutics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 289,410 Iterum Therapeutics shares in Q1 2026, an estimated $97K.
Jane Street first reported a position in Iterum Therapeutics in Q1 2021 and held it in 9 quarters.
Jane Street's Iterum Therapeutics position peaked at $97K in Q4 2025.
18 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.